AbstractIn present study, the potential drug delivery of nanoformulations was validated via the comparison of cellular uptake of nanoparticles in various cell lines and in vivo pulmonary cellular uptake in intratracheally (IT) dosed rat model. Nanoparticles were prepared by a bench scale wet milling device and incubated with a series of cell lines, including Caco-2, RAW, MDCK and MDCK transfected MDR1 cells. IT dosed rats were examined for the pulmonary cellular uptake of nanoparticles. The processes of nanoparticle preparation did not alter the crystalline state of the material. The uptake of nanoparticles was observed most extensively in RAW cells and the least in Caco-2 cells. Efflux transporter P-gp did not prevent cell from nanoparticl...
International audienceAs the lung is one of the main routes of exposure to manufactured nanoparticle...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
This review presents the different pathways that nanomedicines can follow after deposition in the lu...
The deposition characteristics in lungs following inhalation, the potential toxic effects induced an...
The mechanism(s) of nanoparticle-cell interactions are still not understood. At present there is lit...
Lung cancers, the number one cancer killer, can be broadly divided into small cell lung cancer (SCLC...
Nano-size particles show promise for pulmonary drug delivery, yet their behavior after deposition in...
Interest continues to grow in the possibility of understanding the mechanism(s) of nanoparticle-cell...
The increasing use of nanoparticles in products likely results in increased exposure of both workers...
The ability to manipulate the size and surface properties of nanomaterials makes them a promising ve...
Nanoparticles in polluted air or aerosolized drug nanoparticles predominantly settle in the alveolar...
2011-10-28Nanoparticles have at least one dimension between 1 and 100 nm. Inhaled nanoparticles have...
An in vitro model of the human follicle associated epithelium (FAE) was characterized and the influe...
AbstractAs the lung is one of the main routes of exposure to manufactured nanoparticles, we develope...
To determine responses to nanoparticles in a more comprehensive way, current efforts in nanosafety a...
International audienceAs the lung is one of the main routes of exposure to manufactured nanoparticle...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
This review presents the different pathways that nanomedicines can follow after deposition in the lu...
The deposition characteristics in lungs following inhalation, the potential toxic effects induced an...
The mechanism(s) of nanoparticle-cell interactions are still not understood. At present there is lit...
Lung cancers, the number one cancer killer, can be broadly divided into small cell lung cancer (SCLC...
Nano-size particles show promise for pulmonary drug delivery, yet their behavior after deposition in...
Interest continues to grow in the possibility of understanding the mechanism(s) of nanoparticle-cell...
The increasing use of nanoparticles in products likely results in increased exposure of both workers...
The ability to manipulate the size and surface properties of nanomaterials makes them a promising ve...
Nanoparticles in polluted air or aerosolized drug nanoparticles predominantly settle in the alveolar...
2011-10-28Nanoparticles have at least one dimension between 1 and 100 nm. Inhaled nanoparticles have...
An in vitro model of the human follicle associated epithelium (FAE) was characterized and the influe...
AbstractAs the lung is one of the main routes of exposure to manufactured nanoparticles, we develope...
To determine responses to nanoparticles in a more comprehensive way, current efforts in nanosafety a...
International audienceAs the lung is one of the main routes of exposure to manufactured nanoparticle...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
This review presents the different pathways that nanomedicines can follow after deposition in the lu...